CEACAM5 and malignant colon neoplasm: M5A‐IL‐2 ICK displayed potent antitumor effects in CEA+ breast and colon cancers using an immunocompetent mouse model with human CEA transgene expression, including tumor eradication and induction of immune memory when combined with stereotactic radiation therapy (SRT).13